HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical improvement of pityriasis rubra pilaris with combination etanercept and acitretin therapy.

AuthorsKristy F Davis, Jashin J Wu, Jenny E Murase, Fredric R Rosenberg, Erik P Sorenson, Azin Meshkinpour
JournalArchives of dermatology (Arch Dermatol) Vol. 143 Issue 12 Pg. 1597-9 (Dec 2007) ISSN: 1538-3652 [Electronic] United States
PMID18087024 (Publication Type: Case Reports, Letter)
Chemical References
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Acitretin
  • Etanercept
Topics
  • Acitretin (therapeutic use)
  • Drug Therapy, Combination
  • Etanercept
  • Humans
  • Immunoglobulin G (therapeutic use)
  • Male
  • Middle Aged
  • Pityriasis Rubra Pilaris (drug therapy, pathology)
  • Receptors, Tumor Necrosis Factor (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: